Lv3
380 积分 2023-06-09 加入
VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels
10天前
已完结
Efficacy of SGLT2 Inhibitors in Patients With Diabetes and Nonobstructive Hypertrophic Cardiomyopathy
1个月前
已完结
Pathway-selective 5-HT1AR agonist as a rapid antidepressant strategy
7个月前
已完结
Astrocytic Kir4.1 ion channel deficit drives persistent inflammatory facial pain in males
10个月前
已完结
皖公网安备34019202002308
